|
09.00 |
An introduction to Cancer Immunotherapy Tutorial Workshop given by Kurt Ritter, Sanofi, Frankfurt, D |
|---|---|
|
|
|
|
13.00 |
Opening and Welcome Address Pierre Stallforth, Leibniz Institute for Natural Product Research and Infection Biology e.V., Jena, D |
|
13.05 |
Keynote Lecture Sugars & proteins: towards a synthetic biology Benjamin G. Davis, University of Oxford, GB |
| 13.45 |
Micellar Brønsted acid catalysis enables the synthesis of DNA-tagged tetrahydroquinolines avoiding DNA depurination Andreas Brunschweiger, TU Dortmund Universität, D |
| 14.05 |
Insights into the mechanism of cyclic peptide generation by DnaE split-Inteins Sabine Schneider, TU Munich, München, D |
| 14.25 |
Organic chemistry on proteins: Converting a side-reaction into a highly selective method for N-terminal chemical modification of proteins Sanne Schoffelen, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, DK |
| 14.45 |
Access models for EU-OPENSCREEN ERIC Wolfgang Fecke, Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, D |
| 15.05 | COFFEE BREAK |
|
15.25 |
Changed on short notice: Biosynthetic design of nonribosomal peptides Hajo Kries, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena/D |
|
15.45 |
Selective FKBP51 ligands by conformation-specific binding Felix Hausch, TU Darmstadt, D |
| 16.05 |
Targeting protein lysine acetylation in inflammatory lung diseases Frank Dekker, Groningen Research Institute of Pharmacy (GRIP), University of Groningen (RUG), NL |
| 16.25 |
Poster Lectures P32: Trehalose-conjugation enhances toxicity of photosensitizers against mycobacteria C. Jessen-Trefzer, University of Freiburg, Freiburg/D
P09 Multispecific and Promiscuous Monomodular Nonribosomal Peptide Synthetases M. Klapper, Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie - Hans-Knöll-Institut e.V., Jena/D
P12 Identification of interaction partners of ubiquitylated linker histone H1 E. Höllmüller, University of Konstanz, Konstanz/D
P14 Fighting bacterial infections: The development of novel promising anti-virulence agents targeting extracellular metalloproteases S. Yahiaoui, Department of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken/D
P31 Photocaged PP1 disrupting peptides for temporal control of PP1 activity M. Trebacz, Albert-Ludwigs-Universität Freiburg, Freiburg/D
P18 Drug release from supramolecular hydrogels with visible light Z. Pianowski, KIT, Institute of Organic Chemistry, Karlsruhe/D
P28 Optical Control of Sphingosine-1-Phosphate Formation and Function J. Morstein, New York University, New York City/USA
P30 N-Alkylaminoferrocene-based prodrugs activated under oxidative conditions specifically in cancer cells A. Mokhir, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen/D |
| 17.05 |
Changed on short notice: Keynote Lecture Finding novel compound target pairs using chemical genetics Stephen B. Helliwell, Novartis Institutes for BioMedical Research, Basel, CH |
| 17.45 |
Get together and Reception at the Posters |
| 18.30 |
Dinner |
|
20.00 |
General Assembly |
